← Leaderboards
Frederick D Quinn
University Of Georgia
$5,266,673
Attributed
$5,857,108
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,914,608 · 7
FDA$942,500 · 1
By mechanism
R61$1,426,482 · 1
R21$1,118,205 · 3
U01$1,006,212 · 1
U18$942,500 · 1
R33$763,709 · 1
R41$600,000 · 1
Top collaborators
- Mark R Prausnitz3 shared
- Nancy R Manley2 shared
- Noah Kiwanuka1 shared
- Christopher C. Whalen1 shared
Most similar at University Of Georgia
Same institution · by research overlap
- Noah Kiwanuka$3,955,741
- Timothy Randall Hoover$2,060,643
- Michael Stephen Trent$20,572,599
- Jan S Potempa$8,320,419
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionMycobacterium TuberculosisTuberculosisImmune ResponseCellsResponseAnimalsPathogenBacteriaAerosolsPathologyCaviaVaccinationVaccinesLinkLungProductionProteinsSafetyAntibodiesImmuneFutureImmune SystemAnimal Model
Grant awards (16)
Novel Nanoparticle Respiratory Tract Mucosal Vaccine$763,709
R33 · FY2025 · AI · contact PI
Assessing the Mycobacterium tuberculosis carriage state$187,998
R21 · FY2025 · AI · contact PI
Novel Nanoparticle Respiratory Tract Mucosal Vaccine$461,920
R61 · FY2024 · AI · contact PI
Novel Nanoparticle Respiratory Tract Mucosal Vaccine$479,566
R61 · FY2023 · AI · contact PI
Novel Nanoparticle Respiratory Tract Mucosal Vaccine$484,996
R61 · FY2022 · AI · contact PI
Detection of early-stage, active tuberculosis infection and disease progression during treatment using a rapid, inexpensive and simple-to-use microneedle patch diagnostic platform$228,342
R21 · FY2019 · EB
Detection of early-stage, active tuberculosis infection and disease progression during treatment using a rapid, inexpensive and simple-to-use microneedle patch diagnostic platform$208,970
R21 · FY2018 · EB
Detection of early-stage, active tuberculosis infection and disease progression during treatment using a rapid, inexpensive and simple-to-use microneedle patch diagnostic platform$81,999
R21 · FY2018 · EB
Mouse models for TB infection across the lifespan$187,396
R21 · FY2015 · AI
Mouse models for TB infection across the lifespan$223,500
R21 · FY2014 · AI
A novel live intranasal TB vaccine$300,000
R41 · FY2013 · AI · contact PI
A novel live intranasal TB vaccine$300,000
R41 · FY2012 · AI · contact PI
Development of a diagnostic for latent TB$200,000
U18 · FY2012 · FD · contact PI
Development of a diagnostic for latent TB$371,250
U18 · FY2011 · FD · contact PI
Non-invasive Optical Imaging of Select Agent Bacteria in Non-human Primates$1,006,212
U01 · FY2010 · AI · contact PI
Development of a diagnostic for latent TB$371,250
U18 · FY2010 · FD · contact PI